Outcomes of coronary artery bypass surgery using modified del Nido cardioplegia in patients with poor ventricular

Samuel Brown1, Kholoud Nassar1, Jacob Razzouk1

  • 1Department of Cardiothoracic Surgery, Loma Linda University Medical Center, Coleman Pavilion, Suite 21121, 11175 Campus Street, Loma Linda, CA, 92354, USA.

PubMed

Insights

del Nido cardioplegia (DN) is safe for patients with low ejection fraction undergoing coronary artery bypass grafting. Short-term outcomes were similar to conventional cardioplegia (CCP), showing DN as a viable alternative.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Anesthesiology

Background:

  • del Nido cardioplegia (DN) is recognized for its safety in adult patients with normal left ventricular ejection fraction undergoing isolated coronary artery bypass grafting (CABG).
  • The safety and efficacy of DN in patients with diminished left ventricular function (LVEF ≤ 40%) remained to be determined.

Purpose of the Study:

  • To evaluate the safety and short-term outcomes of del Nido cardioplegia (DN) compared to conventional cardioplegia (CCP) in adult patients with low left ventricular ejection fraction (LVEF ≤ 40%) undergoing isolated coronary artery bypass grafting (CABG).

Main Methods:

  • A retrospective analysis of 272 adult patients with LVEF ≤ 40% who underwent isolated CABG between January 2019 and July 2022.
  • Patients were divided into two groups based on surgeon preference: conventional cardioplegia (CCP) and del Nido cardioplegia (DN). Off-pump and beating heart procedures were excluded.
  • Baseline characteristics, intraoperative data, and short-term postoperative outcomes were compared between the CCP and DN groups.

Main Results:

  • No significant differences were observed in baseline characteristics, including mean LVEF (CCP: 32.5 ± 7.4% vs. DN: 33.4 ± 7.29%, p=0.939).
  • The DN group showed a significantly shorter bypass time (113.20 ± 37.2 min vs. 122.43 ± 34.3 min, p=0.043), with no significant differences in urgency, number of grafts, ischemic time, or blood transfusion rates.
  • Postoperative outcomes were similar between groups, including atrial fibrillation incidence (12.2% vs. 8.8%, p=0.403), ICU length of stay (3.7 ± 2.3 vs. 4.3 ± 3.7 days, p=0.886), total length of stay (5.7 ± 3.7 vs. 6.3 ± 4.4 days, p=0.922), and 30-day mortality (3.85% vs. 1.10%, p=0.205).

Conclusions:

  • del Nido cardioplegia (DN) demonstrates equivalent short-term outcomes compared to conventional cardioplegia (CCP) in patients with low left ventricular ejection fraction undergoing isolated coronary artery bypass grafting.
  • DN is a safe and effective alternative to CCP for this patient population, offering comparable clinical results.
Abstract

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...